Participants 335 474 3
level of adenosine deaminase (ADA) in patients with chronic schizophrenia treated with monotherapy of haloperidol, risperidone or clozapine
Participants 608 662 5
parallel groups of patients with chronic schizophrenia
Participants 664 780 7
Eligible participants in the study were 51 patients with chronic schizophrenia with ages ranging from 20 to 45 years
Participants 782 892 4
All participants were inpatients, in the active phase of illness, and met DSM-IV-TR criteria for schizophrenia
